ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.188,34
-1,00%
S&P 500
5.214,08
0,51%
US Dollar vs BRL
5,1418
1,03%
Bitcoin
63.257,69
3,38%
Brent Oil
83,95
0,47%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Evolus Inc (EOLS)

  7. Evolus Inc (EOLS) Notícias

EOLS

Evolus (EOLS)

Evolus Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:EOLS
DataHoraFonteTítuloCódigoCompanhia
07/05/202418:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EOLSEvolus Inc
07/05/202417:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EOLSEvolus Inc
07/05/202417:05Business WireEvolus Reports First Quarter 2024 Results and Provides Business UpdateNASDAQ:EOLSEvolus Inc
23/04/202417:30Business WireEvolus to Report First Quarter Financial Results on May 7, 2024NASDAQ:EOLSEvolus Inc
17/04/202417:05Business WireEvolus Announces Publication of Safety and Duration Data from Phase 2 Study for “Extra-Strength” 40U Formulation of Jeuveau®NASDAQ:EOLSEvolus Inc
12/04/202417:05Business WireEvolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:EOLSEvolus Inc
26/03/202409:00Business WireEvolus to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:EOLSEvolus Inc
11/03/202410:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:EOLSEvolus Inc
11/03/202408:00Business WireEvolus Announces Pricing of $50.0 Million Underwritten Offering of Common StockNASDAQ:EOLSEvolus Inc
07/03/202418:58Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:EOLSEvolus Inc
07/03/202418:42Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EOLSEvolus Inc
07/03/202418:05Business WireEvolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 GuidanceNASDAQ:EOLSEvolus Inc
01/03/202410:30Business WireEvolus Announces Results from European Head-to-Head Filler TrialNASDAQ:EOLSEvolus Inc
27/02/202410:30Business WireEvolus to Participate in Upcoming Leerink Partners and Barclays Investor ConferencesNASDAQ:EOLSEvolus Inc
23/02/202422:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
22/02/202418:30Business WireEvolus to Report Fourth Quarter and Year End 2023 Results and Provide Business Update on March 7, 2024NASDAQ:EOLSEvolus Inc
30/01/202418:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EOLSEvolus Inc
16/01/202419:28Business WireEvolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue, Achieving Record Results and Exceeding Expectations; Issues 2024 GuidanceNASDAQ:EOLSEvolus Inc
11/01/202408:18IH Market NewsWall Street Highlights: Mastercard’s Financial Rise, Citigroup’s $3.8 Billion Charges, and MoreNASDAQ:EOLSEvolus Inc
04/01/202418:05Business WireEvolus Announces the Appointment of Nareg Sagherian to Vice President, Head of Global Investor Relations and Corporate CommunicationsNASDAQ:EOLSEvolus Inc
20/12/202310:00Business WireEvolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in EuropeNASDAQ:EOLSEvolus Inc
12/12/202307:50IH Market NewsHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic Antitrust Loss, and MoreNASDAQ:EOLSEvolus Inc
07/11/202318:16Business WireEvolus Reports Record Third Quarter 2023 Financial Results and Phase II Data for Extra-Strength 40U Formulation of Jeuveau®NASDAQ:EOLSEvolus Inc
06/11/202310:45Business Wire“Extra-Strength” 40U Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Phase II Data Presented at 2023 ASDS Annual MeetingNASDAQ:EOLSEvolus Inc
01/11/202309:45Business WireEvolus to Participate in November Investor ConferencesNASDAQ:EOLSEvolus Inc
25/10/202309:45Business WireFinal Phase 2 Data Evaluating 40U Dose of PrabotulinumtoxinA-xvfs to be Presented at 2023 ASDS Annual MeetingNASDAQ:EOLSEvolus Inc
25/10/202309:45Business WireEvolus to Report Third Quarter 2023 ResultsNASDAQ:EOLSEvolus Inc
18/10/202317:17Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EOLSEvolus Inc
29/08/202309:45Business WireEvolus to Participate in September ConferencesNASDAQ:EOLSEvolus Inc
23/08/202321:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:EOLSEvolus Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:EOLS

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
COGN3
COGNA ON
BOV
PDTC3
Padtec ON
BOV
AZEV4
AZEVEDO PN
BOV
OIBR3
OI ON
BOV
VVEO3
CM Hospitalar ON
BOV
PRIO3
PETRORIO ON
BOV
BHIA3
Grupo Casas Bahia ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
HBRE3
HBR Realty Empreendiment... ON
BOV
ENJU3
Enjoei ON
BOV
ENAT3
ENAUTA ON
BOV
JHSF3
JHSF PART ON
BOV
SGPS3
SPRINGS ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados